Atopalm Panthenol Cream
Everything behind the verdicts on this product: the rule that fired for each concern, the three answers and the documents they rest on, every study on the row with the date it was opened, and the versions of the tables that produced them. Nothing here is edited by hand; it is generated from the same records the verdicts are.
The scaleRecommendedGoodSupportingEarly evidenceNot for thisAvoidhow it works
Engine 5.2.0 · rules 0.5.1 · evidence table ev-2026.10-r231 · computed October 13, 2026 · how we decide · the evidence table · the anchors
for Dryness
Hyaluronic Acid is a reference standard by mechanism for dryness; this cream carries it.
A trial-supported active, or a reference standard by mechanism, at a working level; or a first-line active below its studied range.
- Rule
- R5 → Good choice. A supported active (trial-backed, or a reference standard by mechanism); declared at a working strength, or a labelled active or at a plausible but undeclared level.
q1 = supported · q2 = adequate | plausible
Why this rule exists: Trial-supported or guideline-supported active, adequately or plausibly dosed.
Rule R5 decided 9,843 verdicts across the catalog; “Good choice” is the verdict on 10,340 of 45,446. The full register. - Carrying active
- Sodium Hyaluronate
- 1 · Standing
- Supported — its mechanism is established (a reference standard, not a trial result)
- 2 · Form
- Plausible — concentration not declared; read from the position in the ingredient list
- 3 · Tolerability
- Standard tolerability — drying alcohol
Cautions: drying alcohol. - Evidence dots
- Limited evidence
- What readers report
- No reviews read yet for this product. Shown beside the verdict; never blended into it.
- Verdict since
- September 5, 2026 (unchanged across rebuilds since then)
The studies and documents on the row
- Effectiveness of topical hyaluronic acid of different molecular weights in xerosis cutis treatment in elderly: a double-blind, randomized controlled trial. — Archives of Dermatological Research (Springer) — 36 nursing-home residents aged 60-80, Universitas Indonesia / Cipto Mangunkusumo Hospital; investigator-initiated, no manufacturer authorship on the author list; registered NCT06178367. JOURNAL NOT IN source-tiers.json — recorded conservatively as tier 3 pending an operator registry decision (it is a PubMed-indexed specialty dermatology journal, arguably tier 2). (2024), opened October 13, 2026
- Final report of the safety assessment of hyaluronic acid, potassium hyaluronate, and sodium hyaluronate. — International Journal of Toxicology — Cosmetic Ingredient Review Expert Panel (industry-funded review body). Establishes the declared cosmetic FUNCTION (skin-conditioning agent, used up to 2%); it is a safety assessment and makes no efficacy finding for dryness. (2009), opened October 13, 2026
← Back to the verdict All dryness products → Disclose a concentration or correct a fact →
for Dehydration
Panthenol (Vitamin B5) is a reference standard by mechanism for dehydration; this cream carries it high in the ingredient list.
A trial-supported active, or a reference standard by mechanism, at a working level; or a first-line active below its studied range.
- Rule
- R5 → Good choice. A supported active (trial-backed, or a reference standard by mechanism); declared at a working strength, or a labelled active or at a plausible but undeclared level.
q1 = supported · q2 = adequate | plausible
Why this rule exists: Trial-supported or guideline-supported active, adequately or plausibly dosed.
Rule R5 decided 9,843 verdicts across the catalog; “Good choice” is the verdict on 10,340 of 45,446. The full register. - Carrying active
- Panthenol
- 1 · Standing
- Supported — its mechanism is established (a reference standard, not a trial result)
- 2 · Form
- Adequate — concentration not declared; read from the position in the ingredient list
Studied range: 2.5%, from the trials on the row; needs leave-on contact - 3 · Tolerability
- Standard tolerability — drying alcohol
Cautions: drying alcohol. - Evidence dots
- Limited evidence
Row checked against its sources on July 17, 2026 (evidence table ev-2026.10-r231). - What readers report
- No reviews read yet for this product. Shown beside the verdict; never blended into it.
- Verdict since
- September 5, 2026 (unchanged across rebuilds since then)
The studies and documents on the row
- Cosmetic Ingredient Review assessment of panthenol / dexpanthenol — humectant and moisturizer that raises stratum-corneum water content — reference work
← Back to the verdict All dehydration products → Disclose a concentration or correct a fact →
for Compromised Skin Barrier
Ceramides is a reference standard by mechanism for compromised skin barrier; this cream carries it.
A trial-supported active, or a reference standard by mechanism, at a working level; or a first-line active below its studied range.
- Rule
- R5 → Good choice. A supported active (trial-backed, or a reference standard by mechanism); declared at a working strength, or a labelled active or at a plausible but undeclared level.
q1 = supported · q2 = adequate | plausible
Why this rule exists: Trial-supported or guideline-supported active, adequately or plausibly dosed.
Rule R5 decided 9,843 verdicts across the catalog; “Good choice” is the verdict on 10,340 of 45,446. The full register. - Carrying active
- MLE Pseudoceramide Complex
- 1 · Standing
- Supported — its mechanism is established (a reference standard, not a trial result)
- 2 · Form
- Plausible — concentration not declared; read from the position in the ingredient list
Studied range: 0.5–1%, from the trials on the row; needs leave-on contact; judge it after about 4 weeks - 3 · Tolerability
- Standard tolerability — drying alcohol
Cautions: drying alcohol. - Evidence dots
- Limited evidence
Row checked against its sources on July 17, 2026 (evidence table ev-2026.10-r231). - What readers report
- No reviews read yet for this product. Shown beside the verdict; never blended into it.
- Verdict since
- September 5, 2026 (unchanged across rebuilds since then)
The studies and documents on the row
- Elias PM, Skin Barrier / Coderch et al., ceramides and skin barrier function — ceramides ~50% of SC intercellular lipid mass, essential to the permeability barrier — reference work
← Back to the verdict All compromised skin barrier products → Disclose a concentration or correct a fact →
for Eczema
Panthenol (Vitamin B5) has early evidence for eczema, and emollient therapy is the recognised companion to treating it — a reasonable supporting choice, short of a recommendation.
Nothing here targets the concern directly, but the product’s job — barrier care, gentle cleansing, photoprotection — is the recognised companion to treating it. Rinse-off products carrying leave-on actives land here too.
- Rule
- R8a → Supporting role. An active with early or mechanistic evidence only; declared at a working strength, or a labelled active or at a plausible but undeclared level; the product’s category job is a recognised companion to treating the concern.
q1 = plausible · q2 = adequate | plausible · supportive = true
Why this rule exists: A plausible-tier active in a category with a supportive job: the sentence names the active instead of saying nothing targets the concern (the AmLactin / CeraVe SA case for keratosis pilaris, where no guideline and single trials leave the keratolytics at early evidence).
Rule R8a decided 1,509 verdicts across the catalog; “Supporting role” is the verdict on 7,796 of 45,446. The full register. - Carrying active
- Panthenol
- 1 · Standing
- Plausible — trials support it
- 2 · Form
- Plausible — concentration not declared; read from the position in the ingredient list
Studied range: 5%, from the OTC monograph or label; needs leave-on contact - 3 · Tolerability
- Standard tolerability — drying alcohol
Cautions: drying alcohol. - Evidence dots
- Moderate evidence
Row checked against its sources on July 17, 2026 (evidence table ev-2026.10-r231). - What readers report
- No reviews read yet for this product. Shown beside the verdict; never blended into it.
- Verdict since
- September 5, 2026 (unchanged across rebuilds since then)
The studies and documents on the row
- A new topical panthenol-containing emollient for maintenance treatment of childhood atopic dermatitis: results from a multicenter prospective study — Journal of Dermatological Treatment (2017), opened July 17, 2026
- A cream containing linoleic acid, 5% dexpanthenol and ceramide in the treatment of atopic dermatitis — Asian Pacific Journal of Allergy and Immunology (2024), opened July 17, 2026
← Back to the verdict All eczema products → Disclose a concentration or correct a fact →
for Sensitivity
Mostly gentle: drying alcohol — usable for sensitive skin with a patch test.
Nothing here targets the concern directly, but the product’s job — barrier care, gentle cleansing, photoprotection — is the recognised companion to treating it. Rinse-off products carrying leave-on actives land here too.
- Rule
- F3 → Supporting role. Otherwise — when no earlier rule in this group matched.
otherwise
Why this rule exists: Standard tolerability with a minor weighted leaf.
Rule F3 decided 184 verdicts across the catalog; “Supporting role” is the verdict on 7,796 of 45,446. The full register. - Carrying active
- Panthenol
- 1 · Standing
- Not assessed
No evidence row exists for this active and concern; it is in the research queue. - 2 · Form
- Plausible — concentration not declared; read from the position in the ingredient list
- 3 · Tolerability
- Standard tolerability — drying alcohol
Cautions: drying alcohol. - Evidence dots
- Not from a trial row
- What readers report
- No reviews read yet for this product. Shown beside the verdict; never blended into it.
- Verdict since
- September 5, 2026 (unchanged across rebuilds since then)
← Back to the verdict All sensitivity products → Disclose a concentration or correct a fact →
for Winter Skin
Nothing here targets winter skin directly; occlusive hydration is the recognised companion to treating it, and this cream does that without known triggers.
Nothing here targets the concern directly, but the product’s job — barrier care, gentle cleansing, photoprotection — is the recognised companion to treating it. Rinse-off products carrying leave-on actives land here too.
- Rule
- R8 → Supporting role. An active with early or mechanistic evidence only or an active researched for the concern and found wanting or an active with no evidence row for the concern yet; the product’s category job is a recognised companion to treating the concern.
q1 = plausible | none | not-assessed · supportive = true
Why this rule exists: The category's job (barrier care, humectant hydration, gentle cleansing, photoprotection) is the documented supportive role for this concern. This is the honest verdict for a moisturizer on an acne page.
Rule R8 decided 3,793 verdicts across the catalog; “Supporting role” is the verdict on 7,796 of 45,446. The full register. - Carrying active
- Panthenol
- 1 · Standing
- Not assessed
No evidence row exists for this active and concern; it is in the research queue. - 2 · Form
- Plausible — concentration not declared; read from the position in the ingredient list
- 3 · Tolerability
- Standard tolerability — drying alcohol
Cautions: drying alcohol. - Evidence dots
- Not from a trial row
- What readers report
- No reviews read yet for this product. Shown beside the verdict; never blended into it.
- Verdict since
- September 5, 2026 (unchanged across rebuilds since then)
← Back to the verdict All winter skin products → Disclose a concentration or correct a fact →
as a moisturizer
Does what a moisturizer is for: draws in water, softens and smooths.
- Rule
- J2 → Does the job. The category-job reading is 65 or more.
Category job score over the measured features 65–85. - Measured from the label
- draws in water, softens and smooths, seals moisture in, supplies barrier lipids, right weight for the job
- Tolerability
- Standard tolerability
- Drying alcohol
A verdict is Dermington’s assessment of how well a product’s ingredients fit a concern — never a claim about what the product treats. Every rule is public and the same for every product; a brand cannot buy a reading. How we decide · what has changed · disclaimer.